Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C > T (rs7668258) or UGT1A43 c.142 T > G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy
Purpose To estimate whether epilepsy patients with variant UGT2B7 -161C > T (rs7668258) or UGT1A4*3 c.142 T > G (rs2011425) alleles differ from their wild-type (wt) peers in exposure to lamotrigine. Methods Consecutive adults on lamotrigine monotherapy or lamotrigine + valproate co-treatme...
Gespeichert in:
Veröffentlicht in: | European journal of clinical pharmacology 2023-08, Vol.79 (8), p.1117-1129 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose
To estimate whether epilepsy patients with variant
UGT2B7 -161C
>
T
(rs7668258) or
UGT1A4*3 c.142 T
>
G
(rs2011425) alleles differ from their wild-type (wt) peers in exposure to lamotrigine.
Methods
Consecutive adults on lamotrigine monotherapy or lamotrigine + valproate co-treatment undergoing routine therapeutic drug monitoring, otherwise generally healthy and free of interacting drugs, were genotyped for
UGT2B7 -161C
>
T
and
UGT1A4*3 c.142 T
>
G.
Heterozygous, variant homozygous, or combined heterozygous/variant homozygous subjects were compared to their wt controls for dose-adjusted lamotrigine troughs with adjustment for age, sex, body weight, rs7668258/rs2011425, polymorphisms of efflux transporter proteins
ABCG2 c.421C
>
A
(rs2231142) and
ABCB1 1236C
>
T
(rs1128503), and level of exposure to valproate using covariate entropy balancing.
Results
Of the 471 included patients, 328 (69.6%) were on monotherapy and 143 were co-treated with valproate. Dose-adjusted lamotrigine troughs in
UGT2B7 -161C
>
T
heterozygous (CT,
n
= 237) or variant homozygous (TT,
n
= 115) subjects were closely similar to those in their wt controls (CC,
n
= 119): geometric means ratios (GMRs) (frequentist and Bayes) 1.00 (95%CI 0.86–1.16) and 1.00 (95%CrI 0.83–1.22) for CT vs. CC; and 0.97 (0.81–1.17) and 0.97 (0.80–1.20) for TT vs. CC subjects. Lamotrigine troughs were also closely similar in
UGT1A4*3 c.142 T
>
G
variant carriers (
n
= 106: 102 TG + 4 GG subjects) and wt controls (TT,
n
= 365): GMR = 0.95 (0.81–1.12) frequentist, 0.96 (0.80–1.16) Bayes. GMRs for variant carriers vs. wt controls were around unity also at different levels of exposure to valproate.
Conclusion
Dose-adjusted lamotrigine troughs in epilepsy patients with variant
UGT2B7 -161C
>
T
or
UGT1A4*3 c.142 T
>
G
alleles are equivalent to those in their respective wt peers. |
---|---|
ISSN: | 0031-6970 1432-1041 |
DOI: | 10.1007/s00228-023-03526-z |